TOP NEWS: AstraZeneca signs deal with Ionis for eplontersen treatment Read More
LONDON MARKET PRE-OPEN: Astra strikes deal; Round Hill lassos Moon Read More
IN BRIEF: Redx shares up on USD9 million milestone payment from Astra Read More
LONDON MARKET MIDDAY: Stocks buoyed by Covid studies and treatments Read More
TOP NEWS: Third dose of AstraZeneca vaccine boosts Omicron antibodies Read More
AstraZeneca's treatment Ultomiris gets priority review from US FDA Read More
AstraZeneca's lupus drug Saphnelo recommended for EU approval Read More
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer Read More
TOP NEWS: Astra's Covid antibody retains activity against Omicron Read More
LONDON BROKER RATINGS: Deutsche cuts Abrdn; UBS raises Dunelm Read More
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response Read More
UK Cabinet minister warns of "concerning situation" as Omicron spreads Read More
UK virus cases highest since January with 58,000 new cases on Friday Read More
TOP NEWS: Astra's Covid-19 antibody drug Evusheld gets approval in US Read More
LONDON MARKET MIDDAY: Stocks rise as Omicron virus fears recede Read More
AstraZeneca enters development agreement with Ionis Pharmaceuticals Read More
LONDON BROKER RATINGS: Deutsche Bank raises NatWest, cuts Barclays Read More
LONDON MARKET OPEN: Ferguson rises after robust quarter; Ashtead gains Read More
Study supports flexible second dose options after Pfizer or Oxford jab Read More
AstraZeneca cancer drug Lynparza is granted priority review in US Read More
